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ABSTRACT  1 
Background: Upper limb neurodynamic tests (ULNTs) are used to identify a neuropathic pain 2 
component in patients’ presenting with arm and/or neck pain. Clinical tests with established 3 
diagnostic accuracy are required to not only to inform clinical management but also minimise costs 4 
associated with expensive medical investigations.  5 
Objective: To evaluate the role of ULNTs in assessment of peripheral neuropathic pain and to inform 6 
their value in clinical practice when assessing patients with arm and/or neck symptoms. 7 
Design: Systematic review was undertaken according to published guidelines, and reported in line 8 
with PRISMA-DTA. 9 
Method: Key databases were searched up to 21/11/2017. Inclusion criteria: Patient population 10 
experiencing arm and/or neck symptoms with suspected peripheral neuropathic involvement, 11 
studies that compared ULNT to a reference standard, any study design using primary diagnostic 12 
accuracy data. Two reviewers independently assessed risk of bias (ROB) using QUADAS-2. The overall 13 
quality of evidence was evaluated using GRADE. 14 
Results: Of eight included studies (n=579), four were assessed as low ROB, although all had concerns 15 
regarding applicability. For carpal tunnel syndrome, ULNT1 sensitivity values ranged 0.4-0.93, 16 
specificity 0.13-0.93, positive likelihood ratio 0.86-3.67 and negative likelihood ratio 0.5-1.9. For 17 
cervical radiculopathy ULNT1 and the combined use of four ULNTs had sensitivity of 0.97 (95%CI 18 
0.85-1.00) whereas the ULNT3 was the most specific (0.87, 95%CI 0.62-0.98). Positive likelihood ratio 19 
ranged 0.58-5.68 and negative likelihood ratio 0.12-1.62.  20 
Conclusion: Based on the available evidence ULNTs cannot be utilised as a stand-alone test for the 21 
diagnosis of CTS. Limited evidence suggests that ULNTs may be clinically relevant for the diagnosis of 22 
CR, but only as a “ruling out” strategy. However, the overall quality of the body of evidence after 23 
applying the GRADE approach was low to very low across studies. Further higher quality research is 24 
needed to establish firm conclusions.  25 
 26 
 27 
Key words: entrapment neuropathies, carpal tunnel syndrome, cervical radiculopathy, upper limb 28 
neurodynamics, validity 29 
 30 
Word count 3685 31 
 32 
 33 
 34 
 35 
 36 
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INTRODUCTION 37 
Peripheral neuropathic pain (PNP) is a term used to describe pain that results from a lesion or 38 
disease affecting the somatosensory nervous system (Finnerup et al., 2016). PNP can arise when a 39 
peripheral nerve trunk or a nerve root has been subject to injury, compression, inflammation or 40 
ischemia resulting in reduced physical capabilities of the nervous system (Nee and Butler, 2006). 41 
Symptoms and signs in neuropathies can be classified as positive (gain of function) or negative (loss 42 
of function). Positive symptoms include pain, paresthesia, dysesthesia, hyperalgesia and allodynia 43 
and indicate abnormal excitability in the nervous system, whereas negative symptoms, such as 44 
hypoesthesia or anesthesia and weakness reflect reduced impulse conduction (Woolf, 2004).  45 
The most common conditions affecting the peripheral nervous system are entrapment neuropathies 46 
(EN), with carpal tunnel syndrome (CTS), cubital tunnel syndrome and cervical radiculopathy (CR) 47 
being examples which contribute considerably to the socioeconomic burden of occupational related 48 
musculoskeletal complaints and the associated costs. Individually EN have been associated with 49 
severe pain, depression and functional limitations (Fernadez-de-las-Penas et al., 2015). CTS is often 50 
observed in activities involving repetitive manual tasks, forceful wrist movements or with direct 51 
pressure on the wrist, estimated to affect 2-15% of workers (Atroshi et al., 1999) and costing more 52 
than 2 billion dollars each year in the USA (work absenteeism, medical evaluation, treatment) (Saint-53 
Lary et al., 2015). In the case of CR, the data regarding the prevalence and the epidemiology of the 54 
condition are very limited.  The reported annual incident of CR is 83.2 per 100.000 persons (107.3 for 55 
men and 63.5 for women) with a peak incidence in the fifth and sixth decade for both genders 56 
(Radhakrishnan et al., 1994).  57 
The diagnosis of EN is based on information received during the subjective (history taking) and 58 
physical examination, which is then confirmed via diagnostic imaging or electrophysiological studies. 59 
Clinical examination of EN encompasses a variety of tests (sensation, muscle strength and reflexes) 60 
assessing the integrity and ability of the nervous system to conduct afferent or efferent impulses 61 
(loss of function) (Baselgia et al., 2017). In addition, a thorough examination includes evaluation of 62 
increased mechanical sensitivity of the nervous system, since PNP can be present without or with 63 
minimal loss of nerve conduction (Schmid et al., 2009). Diagnostic imaging and electrophysiological 64 
studies are most commonly used to establish a diagnosis of EN (Wainner et al., 2003). For most 65 
clinicians, these methods are accessible but given the waiting time for patients and the high cost for 66 
the society it would be useful to establish accurate clinical examination tests for the diagnosis of EN. 67 
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Neurodynamic tests are used by musculoskeletal physiotherapists in order to identify changes of 68 
mechanosensitivity in the nervous system, thus assessing gain of function (Baselgia et al., 2017). Due 69 
to the interdependence of the mechanical, electrical and chemical properties of the nervous system, 70 
changes in one of these features may affect the others (Butler, 2008). Impairments in the 71 
surrounding musculoskeletal structures could apply mechanical or chemical stimuli to a nerve, 72 
resulting in venous congestion, impaired axoplasmic flow, inflammation and development of 73 
mechanosensitive abnormal impulse generating sites (Nee and Butler, 2006).  74 
For disorders affecting the upper limbs four different neurodynamic tests have been proposed to 75 
assess mechanosensitivity of the brachial plexus, medial, radial and ulnar nerve (Elvey, 1980)(Table 76 
1). Where symptoms are not related to central pain mechanisms (broader distribution of symptoms 77 
due to central sensitization e.g. in case of persistent pain) a positive test response could be 78 
associated with neural or non-neural tissue sensitivity. A neurodynamic test is considered positive if 79 
it can reproduce the patient’s own symptoms and if those symptoms can be altered through 80 
structural differentiation (Butler, 2000). Schmid and colleagues (2009) assessed the reliability of 81 
ULNTs and found that those tests have moderate reliability. Wainner et al. (2003, 2005) reported 82 
substantial to almost perfect reliability for the interpretation of theULNT1 (median) and ULNT2b 83 
(radial). 84 
  85 
Although used by clinicians the diagnostic accuracy of upper limb neurodynamic tests (ULNTs) has 86 
not yet been fully established and is important to optimise patient care. A recent systematic review 87 
has summarized the evidence on diagnostic performance of tests (including ULNTs) which are 88 
utilized for the identification of CR and concluded that when consistent with patient history, a 89 
combined result of four negative ULNTs (high sensitivity) and a negative Arm Squeeze test could be 90 
used to rule out the disorder (Thoomes et al., 2017). Likewise an earlier systematic review, 91 
concluded that a positive Spurling’s, traction/neck distraction, and Valsalva’s test might be indicative 92 
of CR, while a negative ULNT1 might be used to rule it out (high sensitivity)(Rubinstein et al., 2007). 93 
Of the eight included studies in this systematic review only two had assessed the diagnostic accuracy 94 
of ULNTs.  Finally in a previous clinical commentary the authors attempted to summarise the 95 
available evidence in regard to the diagnostic usefulness of neurodynamic tests (Nee et al., 2012). 96 
The authors, based on biomechanical and experimental studies, concluded that ULNTs can 97 
potentially distinguish pain related to neural mechanosensitivity from pain arising from other 98 
tissues, and therefore could detect PNP. In the view of the growing body of evidence, a systematic 99 
review is required to evaluate the quality and synthesis the available current evidence of the 100 
diagnostic accuracy of ULNTs and to inform clinical practice.  The aim therefore of this study was to 101 
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examine the intended role of ULNTs in assessment of PNP, by answering the following research 102 
question: What is the diagnostic accuracy of ULNTs when compared to diagnostic imaging or 103 
electrophysiologic studies, and how results from ULNTs can be interpreted when assessing patients 104 
with arm and/or neck symptoms? 105 
 106 
Order of 
movements 
ULNT1 (median) ULNT2a 
(median) 
ULNT2b (radial) ULNT3 (ulnar) 
1 Shoulder depression Shoulder 
depression 
Shoulder depression Shoulder depression 
2 Shoulder abduction 
110° 
Elbow extension  Elbow extension  Shoulder abduction 
100° 
3 Wrist and fingers 
extension 
Lateral rotation 
of the arm  
Medial rotation arm Lateral rotation arm 
4 Forearm supination Wrist and finger 
extension  
Wrist and fingers 
flexion 
Forearm pronation 
5 Shoulder lateral 
rotation 
Shoulder 
abduction 10° 
Shoulder abduction Elbow flexion 
6 Elbow extension Contralateral 
lateral flexion of 
the cervical 
spine 
Contralateral lateral 
flexion of the 
cervical spine 
Wrist and fingers 
extension 
7 Contralateral lateral 
flexion of the cervical 
spine 
  Contralateral lateral 
flexion of the 
cervical spine 
 107 
Table 1. ULNT procedure 108 
 109 
DESIGN AND METHODS 110 
This systematic review was conducted according to a pre-defined protocol based on the Cochrane 111 
Handbook for Diagnostic Test Accuracy studies (Deeks, Wisniewski and Davenport, 2013) and the 112 
Centre for Reviews and Dissemination (CRD, 2009). In addition, the study is reported according to 113 
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy 114 
Studies (PRISMA-DTA) (McInnes et al., 2018). (Appendix 1) 115 
Search strategy 116 
Informed by subject (NH, KK, YV) and methodological experts (NH, CA) key bibliographic databases 117 
were searched independently by two reviewers (KK, YV). The search employed sensitive topic-based 118 
strategies designed for each database from inception to 21
st
 November 2017. Databases of interest 119 
were: PEDro, MEDLINE (through PubMed), AMED, CINAHL, Cochrane Library, and EMBASE. The 120 
search strategy, informed by scoping search included MeSH terms and text words, as well as a 121 
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combination of both for a comprehensive search. The following keywords and combination of them 122 
were used: upper limb neurodynamic test, neural provocation test, upper limb tension test, 123 
diagnosis, peripheral neuropathic pain, peripheral entrapment neuropathy, radicular pain, cervical 124 
radiculopathy, brachial plexus, carpal tunnel syndrome, cubital tunnel syndrome, accuracy, 125 
specificity, sensitivity, validity. 126 
The search was augmented using reference lists of included studies, as well as searching the grey 127 
literature. Box 1 details the MEDLINE search strategy. 128 
 129 
                                     130 
  131 
 132 
 133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
Box 1. MEDLINE search strategy 155 
 156 
Eligibility criteria 157 
Eligibility criteria were established following the recommendations of The Cochrane Handbook for 158 
Diagnostic Test Accuracy studies (Bossuyt and Leeflang, 2008) and informed using the SPIDER search 159 
concept (Cooke, Smith and Booth, 2012). Titles and abstract of the identified studies were screened 160 
by two independent reviewers (KK, YV) for eligibility using pre-specified inclusion criteria. 161 
 
1. peripheral neuropathic pain.mp or exp Neuralgia/ 
2. radicular pain.mp or exp Hereditary Sensory and Autonomic Neuropathies/ 
3. peripheral entrapment neuropathy.mp 
4. cervical radiculopathy.mp or exp Radiculopathy/ 
5. carpal tunnel syndrome.mp or  exp Carpal tunnel syndrome/ 
6. cubital tunnel syndrome.mp or exp Cubital tunnel syndrome/ 
7. brachial plexus neuropathies.mp or exp Brachial plexus neuropathies/ 
8. exp Nerve compression syndromes/ 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
10. upper limb neurodynamic test.mp 
11. upper limb tension test.mp 
12. neural provocation test.mp 
13. exp Diagnosis/ 
14. exp Pain measurements/ 
15. exp Neurologic examination/ 
16. exp Physical examination/ 
17. 10 or 11 or 12 or 13 or 14 or 15 or 16  
18. diagnostic accuracy.mp 
19. sensitivity and specificity.mp or exp Sensitivity and specificity/ 
20. validity.mp 
21. exp Reproducibility of results/ 
22. exp Predictive value of tests/ 
23. 18 or 19 or 20 or 21 or 22 
24. 9 and 17 and 23 
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Inclusion criteria (based on SPIDER) included that the sample (S) comprised populations aged > 18 162 
years with arm and/or neck symptoms with suspected peripheral neuropathic involvement (signs 163 
and symptoms suggesting excitability in the nervous system such as pain, paresthesia, dysesthesia, 164 
spasm or reduced impulse conduction such as hypoesthesia or anesthesia and weakness)(Nee and 165 
Butler, 2006);  the phenomenon of interest (PI) was the diagnostic accuracy of ULNTs; investigated 166 
using a diagnostic accuracy study design (D); with comparison of the index test (ULNTs) to a 167 
reference standard, such as, electrophysiologic examination (electromyography and nerve 168 
conduction studies) or advanced imaging (e.g. Magnetic Resonance Imaging (MRI), CT, myelography) 169 
(E). Although not perfect, these tests are considered to be the most accurate diagnostic tests 170 
available (Wainner, et al., 2003; Jablecki et al., 1993, 2002; Kuijper et al., 2009;). 171 
Exclusion criteria: case series, case reports, surgical or cadaveric studies; publications for which full 172 
text not available. 173 
Quality assessment 174 
Two reviewers (KK, YV) independently conducted the risk of bias (ROB) assessment using the Quality 175 
Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) - tool, a development of the original tool 176 
(Whiting et al., 2011). It consists of four key domains: patient selection, index test, reference 177 
standard and, flow and timing. All key areas are assessed for ROB, whereas the first three are also 178 
assessed in terms of applicability to the review question. Each domain is judged as “high risk”, “low 179 
risk” or “unclear risk” based on signaling questions aiming to assist judgment (Whiting et al., 2011). 180 
Overall, a study can be judged as having “low risk of bias” if every domain has been ranked as “low 181 
risk”. Assessment of applicability is based on the first three domains and whether they are in line 182 
with the review question. The study is judged as having “no concerns” regarding applicability if these 183 
domains are in line with the review question and “with concerns” if deviates from the review 184 
objective. The QUADAS-2 has been used in recent systematic reviews (Grødahl et al., 2016; Hegedus 185 
et al., 2012) and is recommended by the Cochrane Collaboration and the U.K National Institute for 186 
Health and Clinical Excellence (Reitsma et al., 2009).  187 
 188 
Data extraction 189 
Diagnostic accuracy data and study characteristics were extracted by one reviewer (KK) using a pre-190 
designed data extraction sheet which covered five areas. The data were audited by a second 191 
reviewer (YV) for accuracy. The following data were extracted: authors and publication details, 192 
studies’ methods (aim of study, study design, method of recruitment, eligibility criteria, and ethical 193 
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approval), participant details, diagnostic test data (sensitivity, specificity, predictive values, 194 
likelihood ratios and other). Finally, the fifth section was 2x2 contingency tables for the diagnostic 195 
tests.    196 
Summary measures 197 
Sensitivity, specificity, likelihood ratios (LR) and predictive values (PV) were the outcomes for which 198 
data were sought. True positive, false positive, true negative and false negative values were 199 
summarised. In cases where only incomplete or raw data were presented, a 2x2 contingency table 200 
was used to re-estimate these values. Sensitivity and specificity were graded as low (<0.50), 201 
low/moderate (0.51-0.64), moderate (0.65-0.74), moderate/high (0.75-0.84) and high (>0.85) in line 202 
with previous systematic reviews of diagnostic accuracy studies (Grødahl et al., 2016; Schneiders et 203 
al., 2012). Clinical interpretation of likelihood ratios was based on Jaeschke et al. (1994) as follows: 204 
conclusive evidence (LR+>10 and LR-<0.1), strong diagnostic evidence (LR+ 5 to 10 and LR- 0.1 to 205 
0.2), weak diagnostic evidence (LR+2 to 5 and LR- 0.2 to 0.5) and negligible evidence (LR+ 1 to 2 and 206 
LR- 0.5 to 1). 207 
Data analysis 208 
Homogeneity among studies was explored to evaluate if the studies were suitable for combining in a 209 
meta-analysis. Areas of exploration were: study designs, patient population, comparable reference 210 
tests and diagnostic data, no differences in diagnostic thresholds (Burgess et al., 2011). In addition, 211 
quality assessment of the included studies was conducted, since studies with high ROB often over-212 
estimate the performance of a test (Lijmer et al., 2002). Given the heterogeneity of the included 213 
studies a narrative synthesis was undertaken.    214 
Quality of evidence across studies 215 
Quality of evidence, including risk of bias across studies was evaluated using GRADE (Schunemann et 216 
al, 2008) for individual tests. Quality of overall body of evidence is influenced by amongst other 217 
factors, study design, patient populations, precision, consistency, directness and as such each 218 
outcome was evaluated by both reviewers independently (Schunemann et al, 2008). 219 
 220 
 221 
 222 
 223 
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RESULTS 224 
Study identification 225 
The searches identified 1802 studies with screening of title and abstract resulting in 15 studies that 226 
were retrieved for full-text evaluation and 8 studies (n=579) meeting the eligibility requirements for 227 
inclusion. (Fig.1). There was 100% of agreement between the reviewers on selecting studies.  228 
   229 
Fig.1. PRISMA flow diagram for systematic reviews 230 
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Study description 231 
Table 2 summarises the specific characteristics of all eight studies. Three studies investigated the 232 
diagnostic accuracy of ULNTs in individuals with suspected CR (Wainner et al., 2003; Apelby-Albrecht 233 
et al., 2013; Ghasemi et al., 2013). Two of the studies used electrophysiologic procedures as the 234 
reference standard (Wainner et al., 2003; Ghasemi et al., 2013). One study used MRI, clinical 235 
examination and history as a reference standard (Apelby-Albrecht et al., 2013). Five studies 236 
investigated the diagnostic accuracy of ULNTs in individuals with suspected CTS with nerve 237 
conduction studies as the reference standard (Wainner et al., 2005; Vanti et al., 2011, 2012; Bueno-238 
Gracia et al., 2016; Trillos et al., 2017;). 239 
 240 
 241 
 242 
 243 
 244 
 245 
 246 
 247 
 248 
 249 
 250 
 251 
 252 
 253 
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Author. 
(year), 
country 
Type of 
study 
Pathology Setting Inclusion/ Exclusion criteria Population 
(Number, 
gender, age) 
Outcome 
measures 
Reference 
Standard 
ROB 
Apelby-
Albrect et 
al. (2013) 
 
Sweden 
 
 
 
Prospective 
cohort  
Cervical 
radiculopathy  
 
Center for 
spinal surgery 
Inclusion: neck/ arm pain 
 
Exclusion: History of multitrauma, 
malignant, system disease with possible 
neuropathy, or patients whose general 
condition (physically or/and 
psychologically) could influence the 
results. 
N= 51 
Women n=27 
Men n=24  
 
Mean age: 51 
(25-67) years 
ULNT  
(1, 2a, 2b, 3) 
Combined and 
individually  
  
MRI, Clinical 
examination, 
Patient history 
At risk 
Ghasemi et 
al. (2013) 
 
Iran 
Cross-
sectional  
Cervical 
radiculpathy 
Electordiagnostic 
center (hospital) 
Inclusion: Aged > 20 years, symptoms of 
neck/ radicular pain > 3 weeks 
 
Exclusion: History of neck trauma, prior 
surgery, tumors or congenital 
abnormality of cervical spine, any 
systemic situation known to cause 
peripheral neuropathies and known cases 
of rheumatoid arthritis 
N= 97 
Women n=72  
Men n=25  
 
Mean age: 
Women 46.14  
±11.45 
Men 46.32 
±13.97 
years 
ULNT 1 (median) 
 
NCS At risk 
Wainner et 
al. (2003) 
 
 
Prospective 
cohort  
Cervical 
radiculopathy  
University of 
Pittsburgh, 
Wilford Hall 
USAF Medical 
Center, Brooke 
Army Medical 
Center, and 
Blanchfield Army 
Community 
Hospital 
Inclusion:  signs and symptoms compatible 
with CR or CTS 
Exclusion: systemic disease, primary report of 
bilateral radiating arm pain, history of 
conditions involving the affected upper 
extremity or surgical procedures for 
pathologies giving rise to neck pain or CTS,  
discontinuation of work > 6 months, previous 
EMG and  NCS testing the symptomatic limb 
for CR, CTS, or both 
N= 82 
Women n=41  
Men n=41  
 
Mean age: 45  
± 12 years 
ULNT 1 (median),  
ULNT 2b (radial) 
Needle EMG 
and NCS 
Low risk 
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Bueno-
Gracia et 
al. (2016) 
 
Spain 
 
Prospective 
cohort  
Carpal tunnel 
syndrome 
Not reported Inclusion: patients with hand, wrist or 
forearm symptoms  
 
Exclusion: any ROM limitations of the 
upper limb, inability to lie supine, any 
physical contraindications for physical 
therapy, presence of any cognitive or 
communicative deficits  
N= 58 
Women n=42  
Men n=16  
 
Mean age: 54.3  
± 14.5 years 
ULNT 1 (median) 
 
NCS and 
clinical 
presentation 
At risk 
Trillos et 
al. (2017) 
 
Colombia 
 
 
Prospective 
cohort  
Carpal tunnel 
syndrome 
Health service 
institution 
Inclusion: age 18-86, referred with a 
clinical diagnosis of CTS 
 
Exclusion: upper limb joint and cervical 
spine pathologies,  patients with history 
of rheumatoid arthritis, anterior shoulder 
dislocation, CRPS, Raynaud’s syndrome, 
breast cancer,  RC injuries, patients with 
cervical spinal stenosis, or cognitive 
deficits 
N=118 
Women n=98  
Men n=20  
 
Mean age:  
50.51  
±11.1 years 
ULNT 1 (median) NCS Low risk 
Vanti et al. 
(2011) 
 
Italy 
Prospective 
cohort  
 Carpal tunnel 
syndrome 
Clinic of 
Occupational 
Medicine of the 
University of 
Bologna (Italy) 
Inclusion: individuals with suspected CTS 
 
Exclusion: upper limb joint pathologies 
inflammatory, infective or systemic 
pathologies, history of surgical procedure 
for CTS, CR, cognitive deficits 
N= 44 
Women n=33  
Men n=11  
 
Mean age: 46.3  
±10.8 years 
ULNT 1 (median) 
  
NCS At risk 
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ROM: Range of motion, ULNT: Upper limb neurodynamic test, NCS: Nerve conduction studies, CTS:Carpal tunnel syndrome, CRPS: Complex regional pain 
syndrome, RC: Rotator cuff, CR:Cervical radiculopathy, EMG: Electromyography  
Table 2. Characteristics of included studies 
Vanti et 
al.(2012) 
 
Italy 
Prospective 
cohort  
Carpal tunnel 
syndrome 
Occupational 
Medicine of the 
Department of 
Internal 
Medicine, 
Geriatrics and 
Nephrology, 
Alma Mater 
Studiorum, 
University of 
Bologna (Italy) 
Inclusion:  individuals  with suspected CTS 
 
Exclusion: upper limb joint pathologies 
that could significantly limit the ROM of 
the upper limbs; inflammatory, systemic, 
or infectious diseases; history of surgical 
intervention for CTS; CR; and cognitive 
deficits 
N= 47 
Women n=35  
Men n=12  
 
Mean age: 45.9  
± 10.6 years 
ULNT 1 (median) 
 
NCS Low risk 
Wainner et 
al. (2005) 
Prospective 
cohort  
Carpal tunnel 
syndrome  
Multicenter 
medical center 
and community 
hospital 
Inclusion: signs and symptoms compatible 
with CR or CTS 
Exclusion: systemic disease, primary report of 
bilateral radiating arm pain, history of 
conditions involving the affected upper 
extremity or surgical procedures for 
pathologies giving rise to neck pain or CTS,  
discontinuation of work > 6 months, previous 
EMG and  NCS testing the symptomatic limb 
for CR, CTS, or both 
N= 82 
Women n=41  
Men n=41  
 
Mean age: 45 
±12 years 
ULNT 1 (median) 
ULNT 2b  (radial)  
NCS and 
clinical 
presentation 
Low risk 
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Risk of bias assessment 254 
Agreement of risk of bias following discussion was excellent (100%). Four studies were 255 
assessed as “low risk of bias” (ROB) (Wainner et al., 2003, 2005; Vanti et al., 2012; Trillos et 256 
al., 2017), but all of them had concerns with regards to applicability (Table 3). Patient 257 
selection procedures and poor reporting of flow and timing were the main areas of ROB. 258 
Only two studies were assessed as no concerns for applicability (Fig. 2) (Apelby-Albrecht et 259 
al., 2013; Bueno-Gracia et al., 2016). Interpretation of the index test was the main reason for 260 
concern regarding applicability since it was not in agreement with our review question. In 261 
our study an ULNT is considered positive only when it reproduces the patient’s clinical 262 
symptoms and those symptoms are modified with structural differentiation (Nee et al., 263 
2012; Butler, 2000; Coppieters et al., 2002). 264 
 265 
 266 
Study RISK OF BIAS Summary APPLICABILITY CONCERNS Summary 
PATIENT 
SELECTION 
INDEX 
TEST 
REFERENCE 
STANDARD 
FLOW 
AND 
TIMING 
 PATIENT 
SELECTION 
 
INDEX 
TEST 
REFERENCE 
STANDARD 
 
Apelby-
Albrecht 
et al., 
2013 
 
☺ 
 
☺ 
 
☺ 
 
 
At risk  
☺ 
 
☺ 
 
☺ 
No 
concern 
Bueno-
Gracia et 
al., 2016 
 
  
 
☺ 
 
☺ 
 
☺ 
 
At risk 
 
☺ 
 
☺ 
 
☺ 
No 
concern 
Ghasemi 
et al., 
2013 
 ? ? ? At risk ☺  ☺ With 
concern 
Trillos et 
al., 2017 
☺ ☺ ☺ ☺ Low risk ☺  ☺ With 
concern 
Vanti et 
al., 2011 
☺ ☺ ☺  At risk ☺  ☺ With 
concern 
Vanti et 
al., 2012 
☺ ☺ ☺ ☺ Low risk ☺  ☺ With 
concern 
Wainner 
et al., 
2003 
☺ ☺ ☺ ☺ Low risk ☺  ☺ With 
concern 
Wainner 
et al., 
2005 
☺ ☺ ☺ ☺ Low risk ☺  ☺ With 
concern 
 267 
Table 3. Risk of bias assessment of included studies  268 
 269 
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 270 
Fig.2. Proportion of studies assessed as low, high or unclear ROB and/or applicability. 271 
 272 
Synthesis of results 273 
The main limitations for performing a meta-analysis were the heterogeneity in terms of the 274 
reference standard utilised, as well as in the interpretation of the index test and the 275 
methodological quality of the included studies. Since a meta-analysis was not possible, 276 
diagnostic accuracy data (sensitivity, specificity, predictive values and likelihood ratios) are 277 
presented using a narrative approach. The overall body of the evidence in terms of ROB, 278 
inconsistency, indirectness, imprecision, and the presence of potential reported bias after 279 
applying the GRADE approach was low to very low across studies and across outcomes. 280 
Diagnostic accuracy for all clinical indicators is summarised in Table 4 and 5 and outcome of 281 
GRADE evaluation in Table 6 and 7.   282 
Diagnostic accuracy of Upper Limb Neurodynamic tests  283 
Carpal tunnel syndrome 284 
Five studies examined the diagnostic accuracy of ULNTs in patients with suspected CTS 285 
(Wainner et al., 2005; Vanti et al., 2011, 2012; Bueno-Gracia et al., 2016; Trillos et al., 2017). 286 
From these studies two were at ROB (Vanti et al., 2011; Bueno-Gracia et al., 2016) and four 287 
had concerns regarding applicability (Wainner et al., 2005; Vanti et al., 2011, 2012; Trillos et 288 
al., 2017). Those at ROB had limitations related to patient selection and flow and timing. The 289 
study of Vanti et al. (2011) was at ROB because the number of patients enrolled in the study 290 
was different from the number of patients that were included in the analysis (Whiting et al., 291 
2011), whereas in the study by Bueno-Gracia et al. (2016) the authors provided limited 292 
information in regards to the methods used for the enrollment of the sample (consecutive or 293 
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random sample). The studies that had concerns regarding applicability used a definition for a 294 
positive ULNT that differs from that being used in this review.  295 
Three studies assessed the validity of ULNT1 (median) considering the test positive in the 296 
presence of only one of the following criteria: 1) reproduction of patient’s symptoms; 2) side 297 
to side differences (>10°) in elbow extension; 3) contralateral neck side-flexion increased 298 
symptoms or ipsilateral side-flexion decreased symptoms (Wainner et al., 2005; Vanti et al., 299 
2011; Trillos et al., 2017). Sensitivity was moderate/high 0.75 (95%CI 0.58-0.92) (Wainner et 300 
al, 2005) to high 0.91 (95%CI 0.74-0.98) (Vanti et al., 2011) and 0.93 (95%CI 0.88-0.96) 301 
(Trillos et al., 2011). Specificity was low in all 3 studies: 0.13 (95%CI 0.04-0.22) (Wainner et 302 
al., 2005), 0.15 (95%CI 0.05-0.36) (Vanti et al., 2011) and 0.06 (95%CI 0.0-0.33) (Trillos et al., 303 
2017). In the study by Vanti et al. (2011) the authors conducted a second analysis in which 304 
“reproduction of patient’s symptoms” changed to “reproduction of symptoms in the first, 305 
second or third digit”, but again only one of the three criteria was required for a positive 306 
ULNT1. The second analysis revealed low to moderate sensitivity (0.54, 95%CI 0.35-0.72) and 307 
moderate specificity (0.70, 95%CI 0.48-0.85). Overall, none of the interpretations of ULNT1 308 
was capable of ruling in or ruling out a diagnosis of CTS because LRs were between 0.5 and 309 
2.0. 310 
Two studies examined the diagnostic accuracy of ULNT1 using a different interpretation for a 311 
positive test. In these studies the test was considered positive if it was able to reproduce 312 
patient’s symptoms and these symptoms were altered with structural differentiation (Vanti 313 
et al., 2012; Bueno-Gracia et al., 2016). Sensitivity ranged from low 0.05 (95%CI 0.02-0.19) 314 
(Vanti et al., 2012) to low/moderate 0.58 (95%CI 0.45-0.71) (Bueno-Gracia et al., 2016). 315 
Specificity ranged from moderate/high 0.84 (95%CI 0.72-0.96) (Bueno-Gracia et al., 2016) to 316 
high 0.93 (95%CI 0.82-0.98) (Vanti et al., 2012). Bueno-Gracia and colleagues (2016) 317 
suggested that the ULNT1 may be clinically useful to determine patients with CTS due to 318 
high +LR (3.67). However the high number of false negatives results challenges this notion 319 
(Table 4). 320 
 321 
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SD: structural differentiation, SN: sensitivity, SP: specificity, +LR: positive likelihood ratio, -LR: negative likelihood ratio, PPV: positive predictive value, NPV: negative 334 
predictive value, CI: confidence intervals,?: Data not available, authors have been contacted but did not respond 335 
 336 
Table 4. Diagnostic ULNTs accuracy data for CTS337 
Author 
(Year) 
Test (Positive test criteria) SN  
(95% CI) 
SP  
(95% CI) 
+LR  
(95% CI) 
-LR  
(95% CI) 
PPV  
(95% CI) 
NPV  
(95% CI) 
Bueno-Gracia 
et al., 2016 
ULNT1 
Criterion A 
-Patient’s symptoms reproduced and changed with SD 
 
Criterion B 
-Reproduction of symptoms in the wrist and first three digits that changed with SD, regardless of 
the reproduction of patient’s clinical symptoms 
 
0.58  
(0.45-0.71) 
 
0.74  
(0.61-0.83) 
 
0.84  
(0.72-0.96) 
 
0.50  
(0.35-0.65) 
 
3.67  
(1.70-7.89) 
 
1.47  
(1.03-2.10) 
 
0.50  
(0.36-0.70) 
 
0.53  
(0.31-0.90) 
 
0.85  
(0.71-92) 
 
0.69            
(61-75) 
 
0.43 
(36-51) 
 
0.44      
(32-45) 
Trillos et al., 
2017 
ULNT1 
-Any one of the following: (1) patient’s symptoms reproduced; (2) side to side differences (>10°) 
in elbow extension on completion of all motion sequences; (3) change of symptoms with SD 
0.93  
(0.88-0.96) 
0.06  
(0.0-0.33) 
1.00  1.05 0.87 (?) 0.12 (?) 
Vanti et al., 
2011 
ULNT1 
Criterion A 
-Any one of the following: (1) reproduction of patient’s symptoms; (2) side to side differences 
(>10°) in elbow extension on completion of all motion sequences; (3)  change of symptoms with 
SD 
Criterion B 
-Side to side differences (>10°) in elbow extension on completion of all motion sequences, but (1) 
and (3) positive only in presence of symptoms reproduction in the 1
st
, 2
nd
 and 3
rd
 digit of the 
affected arm 
 
0.91  
(0.74-0.98) 
 
 
 
0.54  
(0.35-0.72) 
 
0.15  
(0.05-0.36) 
 
 
 
0.70  
(0.48-0.85) 
 
1.07  
(0.38-3.08) 
 
 
 
1.8  
(1.13-2.88) 
 
0.55  
(0.19-1.59) 
 
 
 
0.65  
(0.41-1.04) 
 
0.56 (?) 
 
 
 
 
0.68 (?) 
 
0.40 (?) 
 
 
 
 
0.44 (?) 
Vanti et al., 
2012 
ULNT1 
Criterion A 
-symptoms in fingers I,II or III 
 
Criterion B 
-A + symptoms increased with controlateral cervical side bending 
 
Criterion C 
-A + symptoms decreased with ipsilateral cervical side bending 
 
0.4  
(0.26-0.56) 
 
0.28  
(0.16-0.45) 
 
 
0.05  
(0.02-0.19) 
 
0.79  
(0.66-0.88) 
 
0.82  
(0.69-0.91) 
 
 
0.93  
(0.82-0.98) 
 
1.96  
(1.27-3.01) 
 
1.6  
(0.93-2.76) 
 
 
0.85  
(0.22-3.30) 
 
0.75  
(0.49-1.16) 
 
0.86  
(0.50-1.49) 
 
 
1.01 
(0.26-3.89) 
 
0.58  
(0.39-0.75) 
 
0.55 
(0.34-0.75) 
 
 
0.4  
(0.12-0.77) 
 
0.65  
(0.52-0.76) 
 
0.59  
(0.47-0.70) 
 
 
0.56  
(0.45-0.67) 
Wainner et 
al., 2005 
ULNT1 
-Any one of the following: (1) patient’s symptoms reproduced; (2) side to side differences (>10°) 
in elbow extension on completion of all motion sequences; (3)  change of symptoms with SD 
ULNT2b 
-Any one of the following: (1) patient’s symptoms reproduced; (2) side to side differences (>10°) 
in elbow extension on completion of all motion sequences; (3)  change of symptoms with SD 
0.75  
(0.58-0.92) 
 
0.64  
(0.45-0.83) 
0.13  
(0.04-0.22) 
 
0.30  
(0.17-0.42) 
0.86  
(0.67-1.0) 
 
0.91  
(0.65-1.3) 
1.9  
(0.72-5.1) 
 
1.2  
(0.62-2.4) 
(?) 
(?) 
(?) 
(?) 
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Cervical radiculopathy 338 
Three studies investigated the concordance of ULNT1 with a reference standard in patients 339 
with suspected CR (Wainner et al., 2003; Apelby-Albrecht et al., 2013; Ghasemi et al., 2013). 340 
The reference standard in two of these studies was NCS and needle electromyography 341 
(Wainner et al., 2003; Ghasemi et al., 2013), whereas in the third study the authors used the 342 
combination of patient history, clinical examination and MRI findings as the reference 343 
standard (Apelby-Albrecht et al., 2013). In two of these studies ULNT1 showed moderate to 344 
high (0.83, 95%CI 0.66-0.93) and high sensitivity (0.97, 95%CI 0.90-1.0) (Apelby-Albrecht et 345 
al., 2013; Wainner et al., 2003) whereas in the third study the sensitivity was low 0.35 for 346 
chronic CR and low/moderate 0.6 for acute CR (Ghasemi et al., 2013). Specificity ranged 347 
from low 0.22 (95%CI 0.12-0.33) (Wainner et al., 2003) and 0.4 (Ghasemi et al., 2013) to 348 
moderate/high 0.75 (95%CI 0.48-0.93) (Apelby-Albrecht et al., 2013). Moreover, in the study 349 
of Wainner et al. (2003) the ULNT1 demonstrated negative likelihood ratio (LR) of 0.12, 350 
meaning that a negative ULNT1 could rule out CR. This study had low ROB, but had concerns 351 
regarding applicability related to the different interpretation of the index test from the 352 
authors compared with the review question (Whiting et al., 2011). In addition, due to wide 353 
95% CI the results of this study should be interpreted cautiously. Wide CIs reduce the 354 
strength of evidence by influencing the precision of the pooled estimates.  355 
The validity of ULNT2b (radial) was assessed by two studies (Wainner et al., 2003; Apelby-356 
Albrecht et al., 2013). Sensitivity was moderate in both studies: 0.66 (95%CI 0.48-0.81) 357 
(Apelby-Albrecht et al., 2013) and 0.72 (95%CI 0.52-0.93) (Wainner et al., 2003). Specificity 358 
ranged from low 0.33 (95%CI 0.21-0.45) (Wainner et al., 2003) to moderate/high 0.75 (95%CI 359 
0.48-0.93) (Apelby-Albrecht et al., 2013).  360 
Apelby-Albrecht and colleagues (2013) also examined the diagnostic accuracy of ULNT2a 361 
(median), ULNT3 (ulnar) and ULNTs combined as a single test. This study was assessed as at 362 
ROB due to the time lapse between the MRI and the neurodynamic testing (up to six 363 
months) (Whiting et al., 2011); however, no concerns regarding applicability were identified. 364 
Combined ULNTs showed high sensitivity (0.97, 95%CI 0.85-1.00) and moderate specificity 365 
(0.69, 95%CI 0.41-0.89) whereas the ULNT3 (ulnar) was the most specific (0.87, 95%CI 0.62-366 
0.98) (Apelby-Albrecht et al., 2013) (Table 5).  367 
 368 
 369 
 370 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
 371 
 372 
 373 
 374 
 375 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
SD: structural differentiation, SN: sensitivity, SP: specificity, +LR: positive likelihood ratio, -LR: negative likelihood ratio, PPV: positive predictive value, NPV: negative 376 
predictive value, CI: confidence intervals,?: Data not available, authors have been contacted but did not respond 377 
 378 
Table 5. Diagnostic ULNTs accuracy data for CR 379 
Author 
(Year) 
Test ( Positive test criteria) SN 
(95% CI) 
SP  
(95% CI) 
+LR (95% CI) -LR  
(95% CI) 
PPV (95% CI) NPV  
(95% CI) 
Apelby-Albert et 
al., 2013 
ULNT1 
-(1) Reproducible neurogenic pain in neck and arm, (2) increased/decreased 
symptoms with SD, (3) difference in painful radiation between right and left 
sides  
 
ULNT2a 
-(1) Reproducible neurogenic pain in neck and arm, (2) increased/decreased 
symptoms with SD, (3) difference in painful radiation between right and left 
sides  
 
ULNT2b 
-(1) Reproducible neurogenic pain in neck and arm, (2) increased/decreased 
symptoms with SD, (3) difference in painful radiation between right and left 
sides 
 
ULNT3 
-(1) Reproducible neurogenic pain in neck and arm, (2) increased/decreased 
symptoms with SD, (3) difference in painful radiation between right and left 
sides 
ULNTcomb. 
-(1) Reproducible neurogenic pain in neck and arm, (2) increased/decreased 
symptoms with SD, (3) difference in painful radiation between right and left 
sides 
0.83  
(0.66-0.93) 
 
 
0.66  
(0.48-0.81) 
 
 
 
0.43  
(0.26-0.61) 
 
 
 
0.71  
(0.54-0.85) 
 
 
0.97  
(0.85-1.00) 
0.75  
(0.48-0.93) 
 
 
0.75  
(0.48-0.93) 
 
 
 
0.75  
(0.48-0.93) 
 
 
 
0.87  
(0.62-0.98) 
 
 
0.69  
(0.41-0.89) 
3.32  
 
 
 
2.64 
 
 
 
 
1.72 
 
 
 
 
5.68 
 
 
 
3.11 
0.22 
 
 
 
0.45 
 
 
 
 
0.76 
 
 
 
 
0.32 
 
 
 
0.04 
0.88  
(0.72-0.97) 
 
 
0.85 
(0.66-0.96) 
 
 
 
0.79  
(0.54-0.94) 
 
 
 
0.93  
(0.76-0.99) 
 
 
0.87  
(0.73-0.96) 
0.67  
(0.41-0.87) 
 
 
0.50  
(0.29-0.71) 
 
 
 
0.37  
(0.21-0.56) 
 
 
 
0.58  
(0.37-0.78) 
 
 
0.92  
(0.62-1.00) 
Ghasemi et al., 
2013 
ULNT1 
-Reproduction of pain in any step 
Acute CR 
Chronic CR 
 
 
0.6 
0.35 
 
 
0.4 
0.4 
 
 
1.0 
0.58 
 
 
1.0 
1.62 
 
 
0.68 (?) 
0.50 (?) 
 
 
0.32 (?) 
0.27 (?) 
Wainner et al., 
2003 
ULNT1 
-Any one of the following: (1) patient’s symptoms reproduced; (2) side to 
side differences (>10°) in elbow extension on completion of all motion 
sequences; (3)  change of symptoms with SD 
 
ULNT2b 
-Any one of the following: (1) patient’s symptoms reproduced; (2) side to 
side differences (>10°) in elbow extension on completion of all motion 
sequences; (3)  change of symptoms with SD 
 
0.97  
(0.90-1.0) 
 
 
0.72  
(0.52-0.93) 
0.22  
(0.12-0.33) 
 
 
0.33  
(0.21-0.45) 
1.3  
(1.1-1.5) 
 
 
1.1  
(0.77-01.5) 
 
0.12  
(0.01-1.9) 
 
 
0.85  
(0.37-1.9) 
(?) 
 
 
 
(?) 
(?) 
 
 
 
(?) 
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 380 
ULNT: upper limb neurodynamic test, RoB: risk of bias, CR: cervical radiculopathy 381 
Table 6. GRADE assessment of evidence (CR) 382 
 No of studies (No of 
patients) 
Accuracy 
measures 
RoB Indirectness Inconsistency Imprecision  Publication bias Quality of evince 
ULNT1 3 studies (n=230) 
  
(Apelby-Albert et al., 
2013; Ghasemi et al., 
2013;  Wainner et al., 
2003) 
Sensitivity 
 
 
Serious 
 
 
 
 
Serious 
 
 
 
 
Serious 
 
 
 
 
Serious 
 
 
 
 
Undetected 
 
 
 
 
Very low 
 
 
 
 
Specificity Serious Serious Very serious Very serious Undetected Very low 
 
ULNT2a 1 study (n=51) 
 
( Apelby-Albert et al., 
2013) 
Sensitivity 
 
 
 
 
Serious 
 
 
 
 
No 
 
 
 
 
No 
 
 
 
 
Very serious 
 
 
 
 
Undetected 
 
 
 
 
Very low 
 
 
 
 
Specificity Serious No No Very serious Undetected Very low 
 
ULNT2b 2 studies (n=133) 
 
(Apelby-Albert et al., 
2013;  Wainner et al., 
2003) 
Sensitivity 
 
 
 
 
Serious 
 
 
 
 
Serious 
 
 
 
 
Very serious 
 
 
 
 
Very serious 
 
 
 
 
Undetected 
 
 
 
 
Very low 
 
 
 
 
Specificity Serious Serious Very serious Serious Undetected Very low 
 
ULNT3 1 study (n=51) 
 
(Apelby-Albert et al., 
2013)   
Sensitivity  
 
 
 
 
Serious 
 
 
 
 
No 
 
 
 
 
No 
 
 
 
 
Very serious 
 
 
 
 
Undetected 
 
 
 
 
Very low 
 
 
 
 
Specificity Serious No No Very serious Undetected Very low 
 
ULNT (combined) 1 study (n=51) 
 
(Apelby-Albert et al., 
2013)   
Sensitivity 
 
 
Serious 
 
 
 
 
No 
 
 
 
 
No 
 
 
Serious 
 
 
Undetected 
 
 
Low 
 
 
Specificity Serious No No Very serious Undetected Very low 
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 No of studies (No of 
patients) 
Accuracy 
measures 
RoB Indirectness Inconsistency Imprecision  Publication bias Quality of evince 
ULNT1 5 studies (n=349) 
(Wainner et al., 2005; Vanti 
et al., 2011, 2012; Bueno-
Gracia et al., 2016; Trillos et 
al., 2017 
Sensitivity 
 
 
 
 
Serious 
 
 
 
Serious 
 
 
 
Serious 
 
 
 
Very serious 
 
 
 
Undetected 
 
 
 
Very low 
 
 
 
 
Specificity Serious Serious Very serious Very serious Undetected Very low 
 
ULNT2b 1 study (n=82) 
 
((Wainner et al., 2005) 
Sensitivity 
 
 
 
No 
 
 
 
Serious 
 
 
 
Serious 
 
 
 
Very serious 
 
 
 
Undetected 
 
 
 
Very low 
 
 
 
Specificity No Serious Serious Very serious Undetected Very low 
 
ULNT: upper limb neurodynamic test, RoB: risk of bias, CTS: carpal tunnel syndrome 383 
Table 7. GRADE assessment of evidence (CTS) 384 
 385 
 386 
 387 
 388 
 389 
 390 
 391 
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DISCUSSION 392 
 393 
The purpose of this study was to evaluate the role of ULNTs in the assessment of PNP and to 394 
reflect on their value in clinical practice in the assessment and diagnosis of patients with arm 395 
and/or neck symptoms. Current research suggests that ULNTs cannot be used in isolation for 396 
the diagnosis of PNP. Specifically, ULNTs cannot be utilised as a stand-alone test in the 397 
clinical setting for the diagnosis of CTS. Limited evidence suggests that ULNTs demonstrate 398 
better diagnostic accuracy and may be clinically relevant for the diagnosis of CR, but only as 399 
a “ruling out” strategy. However, the overall body of the evidence after applying the GRADE 400 
approach was low to very low for all outcomes, therefore any interpretation of these 401 
findings should be made cautiously.  402 
 403 
Carpal tunnel syndrome 404 
Overall, the five studies that examined the validity of ULNT1 are characterised by diversity in 405 
the interpretation of the index test. From these studies only the interpretation by Bueno-406 
Gracia et al. (2016) is in agreement with the review question, that is, the ULNT1 is 407 
considered positive only when it reproduces the patient’s clinical symptoms and those 408 
symptoms are modified with structural differentiation. This criterion is supported by several 409 
authors, who suggest that structural differentiation is necessary in order to distinguish 410 
between neuropathic pain and pain that arises from other somatic sources (Nee et al., 2012; 411 
Butler, 2000; Coppieters et al., 2002).  Using the above definition for a positive test Bueno-412 
Gracia et al. (2016) found that the ULNT1 may has strong ability to identify patients who do 413 
not have CTS (high specificity).  414 
Using a different definition of a positive test Wainner et al. (2005), Vanti et al. (2011) and 415 
Trillos et al. (2017) found that the ULNT1 had moderate/high to high sensitivity. However, 416 
the low specificities and LRs that have been obtained in these studies decrease the 417 
diagnostic accuracy of ULNT1 and suggest that they cannot be considered adequate for the 418 
diagnosis of CTS.   419 
 420 
Cervical radiculopathy 421 
The diagnostic accuracy of ULNTs seems more promising for the diagnosis of CR. Apelby-422 
Albrecht et al. (2013) investigated the validity of ULNTs combined and individually, using the 423 
same definition for a positive test as this review. Individually, ULNT1 and ULNT3 were the 424 
most valid tests for detecting CR. Combining the tests increased the diagnostic accuracy of 425 
ULNTs further, giving an accurate diagnosis in 88.2% of patients.  426 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
24 
 
Whilst findings by Wainnner et al. (2003) are in agreement with the study by Apelby-427 
Albrecht et al. (2013) the authors used a more liberal definition of a positive test. In their 428 
study, the ULNT1 was highly sensitive and had LR- of 0.12 meaning that when the test is 429 
negative, CR can be ruled out. In these studies the vast majority of patients with CR 430 
presented with nerve root compression at C6-C7 level, therefore the diagnostic properties of 431 
ULNTs may be different when the C5 or C8 root level is involved.   432 
Overall, following analysis of the available evidence, ULNTs seem to have no diagnostic 433 
accuracy to inform clinical practice in patients with suspected CTS. In contrast, ULNTs may 434 
be more useful for the diagnosis of CR, but only as a “ruling out” strategy. Nonetheless, 435 
these findings should be interpreted cautiously due to the small number of studies 436 
investigating the diagnostic accuracy of ULNTs and the differences between them in regards 437 
to the interpretation of a positive test.  438 
There are a number of concerns that may explain some of the results obtained in these 439 
studies. Firstly, electrodiagnostic testing provides information in regards to conduction loss 440 
in large myelinated motor neurons and Aβ fibres (Schmid et al., 2013). Increased 441 
mechanosensitivity, however, is related to increased excitability of small-diameter afferents 442 
and sensitization of nociceptors in the nervi nervorum and sinuvertebral nerves (Baron et al., 443 
2010). Moreover, recent evidence suggests that damage of small axons is more common in 444 
entrapment neuropathies than previously believed (Chien et al., 2008; Schmid et al., 2012) 445 
and may occur even before any dysfunction of large axons (Tamburin et al., 2010). Thus, it 446 
becomes apparent that the inability of the criterion standard to identify neuropathies 447 
related to small axons damage may have led to false-negative results in cases where NCS 448 
classified a patient as not having the condition whereas the ULNTs were positive. 449 
Secondly, in a recent study Baselgia et al. (2017) found that >54% of patients with CTS had 450 
negative ULNT1 despite a clear dysfunction in the median nerve, as proven with NCS. The 451 
authors advocated that the non-reproduction of symptoms during neurodynamic testing can 452 
be a sign of a more severe neural dysfunction of the unmyelinated fibres (Baselgia et al., 453 
2017). These findings, could explain some of the false-negative results that have been 454 
obtained in the included studies in cases where the NCS confirmed a diagnosis but the 455 
neurodyamic testing was negative.   456 
 457 
 458 
 459 
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Future direction   461 
A reference standard should be comprehensive enough to accurately inform clinicians in 462 
regards to the diagnostic accuracy of an index test. Given the insufficiency of 463 
electrodiagnostic tests to provide information about the integrity of small-diameter nerve 464 
fibres (Schmid et al., 2013), it becomes apparent that diagnostic accuracy studies need a 465 
supplementary test that will increase the criterion validity of the reference standard. 466 
Quantitative Sensory Testing (QST) provides information for both loss and gain of function, 467 
in large myelinated (Aβ) and thinly myelinated (Aδ) or unmyelinated fibres (C-fibres) (Rolke 468 
et al., 2006). QST protocols include tests that investigate thermal, mechanical and pain 469 
thresholds, and based on the results clinicians could be informed in regards to which type of 470 
nerve fibres might be involved.  Incorporating QST in protocols, may enhance their ability to 471 
correctly classify patients with PNP. Additionally future diagnostic accuracy studies aiming to 472 
investigate the validity of ULNTs in patients with CTS could adopt the principle of 473 
“neurodynamic sequencing” and alter the order of joint movement. Various studies have 474 
shown that the range of motion and the symptoms can be modified by altering the testing 475 
sequence during straight leg raise (Boland and Adams, 2000), slump test (Johnson and 476 
Chiarello, 1997) and ULNT1 (Coppieters et al., 2001). Moving the wrist to extension first 477 
during ULNT1 testing may increase the likelihood of a positive neurodynamic test (Baselgia, 478 
2017). Moreover, consensus as to what defines a positive test would be useful. 479 
Standardisation of the performance and the interpretation of ULNTs are essential to draw 480 
safe inferences for the true diagnostic accuracy of the tests (Nee et al., 2012). Finally, future 481 
diagnostic accuracy studies should evaluate the diagnostic utility of ULNTs for ulnar nerve 482 
EN, since currently there are limited evidence regarding to the validity of ULNTs in 483 
pathologies such cubital syndrome. 484 
 485 
Strengths and limitations 486 
The strengths of this review are that provides clear recommendations for future studies and 487 
emphasises the importance of precisely reported methodologically robust studies. Among 488 
the limitations of this systematic review is that it includes studies only written in English 489 
which may have introduced bias (Song et al., 2002). Whilst we have adopted the grading of 490 
sensitivity and specificity using parameters based on existing reviews we acknowledge 491 
interpretation is context specific; further research is required to validate these categories.  492 
 493 
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CONCLUSION 495 
Based on the available evidence, ULNTs have no diagnostic accuracy to identify patients with 496 
CTS when used in isolation. Limited evidence suggests that ULNTs demonstrate better 497 
diagnostic accuracy and may be clinically relevant for the diagnosis of CR, but only in a 498 
“ruling out” strategy. However, the overall quality of the body of evidence after applying the 499 
GRADE approach was low to very low across studies. Further higher quality research is 500 
needed to establish firm conclusions regarding to the value of ULNTs in the assessment and 501 
diagnosis of patients with arm and/or neck symptoms. 502 
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• Diagnostic accuracy of ULNT in carpal tunnel syndrome is limited  
• Evidence supports ULNTs in cervical radiculopathy only as a “ruling out” strategy  
• NCS may not be adequate to determine diagnostic accuracy of ULNTs  
• Integrating QST with ULNT may enhance classification of patients with PNP 
 
